UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A systematic review and meta-analysis of randomized trials of substituting soymilk for cow's milk and intermediate cardiometabolic outcomes: understanding the impact of dairy alternatives in the transition to plant-based diets on cardiometabolic health

BMC medicine, 2024-08, Vol.22 (1), p.1-16

2024

Volltextzugriff (PDF)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.29, Article 29

2016

Volltextzugriff (PDF)

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.663-670

2016

Volltextzugriff (PDF)

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

Diabetes, obesity & metabolism, 2016-08, Vol.18 (8), p.766-774

2016

Volltextzugriff (PDF)

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.186-190

2016

Volltextzugriff (PDF)

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

Diabetes & metabolism, 2016-02, Vol.42 (1), p.25-32

2016

Volltextzugriff (PDF)

Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practice

Clinical obesity, 2015-10, Vol.5 (5), p.245-255

2015

Volltextzugriff (PDF)

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

Diabetes, obesity & metabolism, 2010-03, Vol.12 (3), p.210-218

2010

Volltextzugriff (PDF)

A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care

Diabetes, obesity & metabolism, 2013-12, Vol.15 (12), p.1093-1100

2013

Volltextzugriff (PDF)

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial

Diabetes care, 1999-06, Vol.22 (6), p.913-919

1999

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

Diabetic medicine, 2018-01, Vol.35 (1), p.121-130

2018

Volltextzugriff (PDF)

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials

Diabetes & metabolism, 2020-09, Vol.46 (4), p.280-287

2020

Volltextzugriff (PDF)

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials

Diabetic medicine, 2018-12, Vol.35 (12), p.1742-1751

2018

Volltextzugriff (PDF)

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Diabetic medicine, 2020-02, Vol.37 (2), p.256-266

2020

Volltextzugriff (PDF)

Gastrointestinal safety across the albiglutide development programme

Diabetes, obesity & metabolism, 2016-09, Vol.18 (9), p.930-935

2016

Volltextzugriff (PDF)

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.615-628

2011

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

Diabetes & metabolism, 2017-10, Vol.43 (5), p.453-459

2017

Volltextzugriff (PDF)

The effect of a dietary portfolio compared to a DASH-type diet on blood pressure

Nutrition, metabolism, and cardiovascular diseases, 2015-12, Vol.25 (12), p.1132-1139

2015

Volltextzugriff (PDF)

Glucose transport in human skeletal muscle cells in culture : stimulation by insulin and metformin

The Journal of clinical investigation, 1992-10, Vol.90 (4), p.1386-1395

1992

Volltextzugriff (PDF)

Viscosity of fiber preloads affects food intake in adolescents

Nutrition, metabolism, and cardiovascular diseases, 2009-09, Vol.19 (7), p.498-503

2009

Volltextzugriff (PDF)

Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada

Canadian Medical Association journal, 1999-05, Vol.160 (9), p.S7

1999

Volltextzugriff (PDF)

A review of the efficacy of rosuvastatin in patients with type 2 diabetes

International journal of clinical practice (Esher), 2004-10, Vol.58 (s143), p.30-40

2004

Volltextzugriff (PDF)

Cellular mechanism of action of metformin

Diabetes care, 1990-06, Vol.13 (6), p.696-704

1990

Volltextzugriff (PDF)

Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD)

Nutrition, metabolism, and cardiovascular diseases, 2013-03, Vol.23 (3), p.227-234

2013

Volltextzugriff (PDF)

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117

2018

Volltextzugriff (PDF)

1 – 25 von 1.508

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(986)
Mit Volltextzugriff
(1.282)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(523)
Life Sciences & Biomedicine
(490)
Humans
(355)
Male
(191)
Female
(184)
Animals
(127)
Middle Aged
(118)
Diabetes
(107)
Endocrinology & Metabolism
(104)
Cardiovascular System & Cardiology
(98)
Cardiac & Cardiovascular Systems
(95)
Diabetes Mellitus
(89)
Risk Factors
(89)
Aged
(88)
Adult
(84)
Mice
(78)
General & Internal Medicine
(74)
Medicine, General & Internal
(69)
Diabetes Mellitus, Type 2 - Drug Therapy
(68)
Social Sciences
(68)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(560)
MEDLINE
(474)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(456)
Ingenta
(350)
De Gruyter eBooks
(249)
NUS Single-Journal Subscriptions
(243)
Access via ScienceDirect (Elsevier)
(201)
JSTOR
(189)
IngentaConnect Journals
(145)
Project MUSE - Single Title Subscriptions
(133)
eBooks on EBSCOhost
(111)
Project MUSE Journals
(110)
Project MUSE
(105)
Literature Online (LION)
(102)
Wiley-Blackwell Journals
(101)
Oxford Journals
(91)
Oxford Journals 2020 Medicine
(82)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(80)
Wiley Online Library
(64)
Ebook Central Perpetual and DDA
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Asian Theatre Journal
(94)
Insight
(50)
Canadian Journal Of Cardiology
(46)
Circulation
(43)
Diabetes
(34)
The Journal Of Clinical Investigation
(26)
Diabetes Care
(24)
European Heart Journal
(21)
Diabetes, Obesity & Metabolism
(20)
The American Journal Of Clinical Nutrition
(19)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A systematic review and meta-analysis of randomized trials of substituting soymilk for cow's milk and intermediate cardiometabolic outcomes: understanding the impact of dairy alternatives in the transition to plant-based diets on cardiometabolic health

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

Identification of educational needs in the management of overweight and obesity: results of an international survey of attitudes and practice

Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Gastrointestinal safety across the albiglutide development programme

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

The effect of a dietary portfolio compared to a DASH-type diet on blood pressure

Glucose transport in human skeletal muscle cells in culture : stimulation by insulin and metformin

Viscosity of fiber preloads affects food intake in adolescents

Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada

A review of the efficacy of rosuvastatin in patients with type 2 diabetes

Cellular mechanism of action of metformin

Altering source or amount of dietary carbohydrate has acute and chronic effects on postprandial glucose and triglycerides in type 2 diabetes: Canadian trial of Carbohydrates in Diabetes (CCD)

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

Aktive Filter

Suchergebnisse filtern